I have a picture for you! 4 December - 10 December 2022
The First Thing newsletter's Ever-lasting Subscriber Photo Gallery.
Stay updated with breaking news from Don Hunter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The First Thing newsletter's Ever-lasting Subscriber Photo Gallery.
A Nova Scotia-based company has received Health Canada approval to conduct a clinical trial to determine if psilocybin, a psychedelic compound found in 'magic' mushrooms, can help those with PTSD who are treatment-resistant.
Halucenex Life Sciences Inc. in Windsor, N.S., is in the midst of the province's first clinical trial using the psychoactive substance psilocybin. Researchers hope to demonstrate the efficacy of the drug for treating post-traumatic stress disorder.
Company announces upcoming CEO change and potential changes to the Board of Directors.BOCA RATON, FL / ACCESSWIRE / October 7, 2022 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN)
Note: This article was updated on Sept. 8, 2022.